FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3035267884> ?p ?o ?g. }

• W3035267884 endingPage "112478" @default.
• W3035267884 startingPage "112478" @default.
• W3035267884 abstract "This paper describes identification of the first-in-class multi-target adenosine A2A receptor antagonists-carbonic anhydrase (CA) IX and XII inhibitors, as new potential antitumor agents. To obtain the multi-acting ligands, the 8-amino-2,6-diphenyltriazolo[4,3-a]pyrazin-3-one, a potent adenosine hA2A receptor (AR) antagonist, was taken as lead compound. To address activity against the tumor-associated CA isoforms, it was modified by introduction of different substituents (OH, COOH, CONHOH, SO2NH2) on the 6-phenyl ring or on a phenyl pendant connected to the former through different spacers. Among the new triazolopyrazines 1–23, the most active were those featuring the sulfonamide residue. Derivative 20, featuring a 4-sulfonamidophenyl residue attached through a CONH(CH2)2CONH spacer at the para-position of the 6-phenyl ring, showed the best combination of activity at the three targets. In fact, it inhibited both the tumor-associated hCA IX and XII isozymes at nanomolar concentration (Ki = 5.0 and 27.0 nM), and also displayed a quite good affinity for the hA2A AR (Ki = 108 nM). Compound 14, bearing the 4-sulfonamidophenyl residue linked at the para-position of the 6-phenyl ring by a CONH spacer, was remarkable because both its hA2A AR affinity and hCA XII inhibitory potency were in the low nanomolar range (Ki = 6.4 and 6.2 nM, respectively). Molecular docking studies highlighted the interaction mode of selected triazolopyrazines in the hA2A AR recognition pocket and in the active site of hCA II, IX and XII isoforms." @default.
• W3035267884 created "2020-06-19" @default.
• W3035267884 creator A5000990423 @default.
• W3035267884 creator A5016294244 @default.
• W3035267884 creator A5017920493 @default.
• W3035267884 creator A5023738095 @default.
• W3035267884 creator A5025337586 @default.
• W3035267884 creator A5028073874 @default.
• W3035267884 creator A5037870901 @default.
• W3035267884 creator A5042943825 @default.
• W3035267884 creator A5048593211 @default.
• W3035267884 creator A5067731409 @default.
• W3035267884 date "2020-09-01" @default.
• W3035267884 modified "2023-10-04" @default.
• W3035267884 title "Discovery of first-in-class multi-target adenosine A2A receptor antagonists-carbonic anhydrase IX and XII inhibitors. 8-Amino-6-aryl-2-phenyl-1,2,4-triazolo [4,3-a]pyrazin-3-one derivatives as new potential antitumor agents" @default.
• W3035267884 cites W1573899446 @default.
• W3035267884 cites W1901981925 @default.
• W3035267884 cites W1990603054 @default.
• W3035267884 cites W1999752442 @default.
• W3035267884 cites W2000050437 @default.
• W3035267884 cites W2001216966 @default.
• W3035267884 cites W2008456349 @default.
• W3035267884 cites W2028094318 @default.
• W3035267884 cites W2034434306 @default.
• W3035267884 cites W2047178318 @default.
• W3035267884 cites W2050456292 @default.
• W3035267884 cites W2051349300 @default.
• W3035267884 cites W2066502054 @default.
• W3035267884 cites W2313639944 @default.
• W3035267884 cites W2396178688 @default.
• W3035267884 cites W2396395844 @default.
• W3035267884 cites W2509135464 @default.
• W3035267884 cites W2526358224 @default.
• W3035267884 cites W2540663276 @default.
• W3035267884 cites W2549186512 @default.
• W3035267884 cites W2556726577 @default.
• W3035267884 cites W2557965571 @default.
• W3035267884 cites W2582022071 @default.
• W3035267884 cites W2591914678 @default.
• W3035267884 cites W2622461769 @default.
• W3035267884 cites W2725693671 @default.
• W3035267884 cites W2754993961 @default.
• W3035267884 cites W2755599483 @default.
• W3035267884 cites W2775184670 @default.
• W3035267884 cites W2783271319 @default.
• W3035267884 cites W2795286490 @default.
• W3035267884 cites W2807392448 @default.
• W3035267884 cites W2809650769 @default.
• W3035267884 cites W2900088247 @default.
• W3035267884 cites W2901821976 @default.
• W3035267884 cites W2907225680 @default.
• W3035267884 cites W2921405939 @default.
• W3035267884 cites W2949238281 @default.
• W3035267884 cites W2952238480 @default.
• W3035267884 cites W2957320468 @default.
• W3035267884 cites W2970547241 @default.
• W3035267884 doi "https://doi.org/10.1016/j.ejmech.2020.112478" @default.
• W3035267884 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32659606" @default.
• W3035267884 hasPublicationYear "2020" @default.
• W3035267884 type Work @default.
• W3035267884 sameAs 3035267884 @default.
• W3035267884 citedByCount "8" @default.
• W3035267884 countsByYear W30352678842021 @default.
• W3035267884 countsByYear W30352678842022 @default.
• W3035267884 countsByYear W30352678842023 @default.
• W3035267884 crossrefType "journal-article" @default.
• W3035267884 hasAuthorship W3035267884A5000990423 @default.
• W3035267884 hasAuthorship W3035267884A5016294244 @default.
• W3035267884 hasAuthorship W3035267884A5017920493 @default.
• W3035267884 hasAuthorship W3035267884A5023738095 @default.
• W3035267884 hasAuthorship W3035267884A5025337586 @default.
• W3035267884 hasAuthorship W3035267884A5028073874 @default.
• W3035267884 hasAuthorship W3035267884A5037870901 @default.
• W3035267884 hasAuthorship W3035267884A5042943825 @default.
• W3035267884 hasAuthorship W3035267884A5048593211 @default.
• W3035267884 hasAuthorship W3035267884A5067731409 @default.
• W3035267884 hasConcept C116569031 @default.
• W3035267884 hasConcept C119795356 @default.
• W3035267884 hasConcept C159110408 @default.
• W3035267884 hasConcept C170493617 @default.
• W3035267884 hasConcept C178790620 @default.
• W3035267884 hasConcept C181199279 @default.
• W3035267884 hasConcept C185592680 @default.
• W3035267884 hasConcept C202751555 @default.
• W3035267884 hasConcept C2775914622 @default.
• W3035267884 hasConcept C2776885963 @default.
• W3035267884 hasConcept C2777752112 @default.
• W3035267884 hasConcept C2780263894 @default.
• W3035267884 hasConcept C2780416268 @default.
• W3035267884 hasConcept C2781076698 @default.
• W3035267884 hasConcept C2911210155 @default.
• W3035267884 hasConcept C41183919 @default.
• W3035267884 hasConcept C41685203 @default.
• W3035267884 hasConcept C55493867 @default.
• W3035267884 hasConcept C71240020 @default.
• W3035267884 hasConcept C71924100 @default.
• W3035267884 hasConceptScore W3035267884C116569031 @default.
• W3035267884 hasConceptScore W3035267884C119795356 @default.

• next